Brexanolone to Treat Postpartum Depression in Adult Women

ZULRESSO (Brexanolone) is a novel FDA-approved treatment for moderate-to-severe postpartum depression. Postpartum depression may be diagnosed in women experiencing depressive symptoms which can manifest as cognitive, behavioral, or emotional disturbances as early as the third trimester to 4 weeks fo...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Psychopharmacol Bull
Main Authors: Cornett, Elyse M, Rando, Lauren, Labbé, Austin M, Perkins, Wil, Kaye, Adam M, Kaye, Alan David, Viswanath, Omar, Urits, Ivan
Formato: Artigo
Idioma:Inglês
Publicado em: MedWorks Media Global 2021
Assuntos:
Review Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8146562/
https://ncbi.nlm.nih.gov/pubmed/34092826
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados